Just to add the Wales perspective — we're on a completely different system. Welsh Government commissioned a separate review and semaglutide for obesity is not yet approved by AWMSG (All Wales Medicines Strategy Group). Our Tier 3 services don't prescribe it at all currently.
Scotland is ahead of England actually — the SMC approved it in 2024 and some NHS boards are already prescribing through their weight management pathways with waits of 4-6 months.
Devolution means four completely different systems for the same drug. Madness.
One more thing — check if your area has the NHS Wegovy pilot programme. It launched in parts of London, Manchester, and the Midlands in late 2025. Patients in the pilot get fast-tracked (2-4 week wait) and get free behavioural support alongside the medication.
I don't think anders_CPH is in the pilot yet, but it's expanding. Novo Nordisk is partly funding it as a real-world evidence study.
This is all incredibly helpful. I'm going to:
- Check the pilot programme — fingers crossed
- Book a private endocrinologist consultation and try the shared-care route mentioned
- Keep the Tier 3 referral active as a backup
The idea that I have to wait 16 months with a BMI of 38, diabetes, and hypertension while the drug is literally approved and sitting in pharmacies is just absurd. But at least there are workarounds. Will update the thread.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL Biochem